GENITOURINARY CANCER
Clinical trials for GENITOURINARY CANCER explained in plain language.
Never miss a new study
Get alerted when new GENITOURINARY CANCER trials appear
Sign up with your email to follow new studies for GENITOURINARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug duo takes on rare cancers: new hope for patients
Disease control OngoingThis study tests a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 100 adults with rare cancers of the urinary or reproductive systems. The goal is to see if the drugs can shrink tumors and control the disease. Participants have cancers that cannot be removed…
Matched conditions: GENITOURINARY CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Engineered immune cells and vaccine take on Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a treatment for adults with metastatic solid tumors (like colorectal, lung, or breast cancer) that have a specific genetic change called KRAS. Doctors take a person's own white blood cells, modify them in a lab to better recognize and attack cancer ce…
Matched conditions: GENITOURINARY CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Talking it out: new program helps cancer patients and caregivers cope and plan together
Symptom relief OngoingThis study tests a program that helps cancer patients and their caregivers manage difficult emotions and communicate better about the illness. It includes a version tailored for Latinx participants. The goal is to reduce distress, improve quality of life, and help families discus…
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Scientists hunt for clues in tumors to match patients with the right cancer drugs
Knowledge-focused OngoingThis study collects tissue and blood samples from 156 people with advanced prostate, kidney, or bladder cancer to find genetic markers that predict how well different treatments will work. Participants give a biopsy of a growing tumor before starting their planned therapy, which …
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
New breathing technique tested in robotic cancer surgery
Knowledge-focused TerminatedThis study aimed to compare two ways of helping patients breathe during anesthesia for robotic gynecological or genitourinary cancer surgery. The goal was to see if a newer method (APRV) improves lung function compared to the standard method (CMV). The study was withdrawn before …
Matched conditions: GENITOURINARY CANCER
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
Tumor testing may unlock better cancer trial matches
Knowledge-focused OngoingThis study looks at tumor samples from over 3,000 people with advanced cancers to find specific genetic markers (biomarkers). The goal is to help doctors choose which targeted therapy clinical trials might work best for each patient. It does not test a new treatment itself, but a…
Matched conditions: GENITOURINARY CANCER
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC